期刊文献+

微粒体环氧化物水解酶基因多态性与中国妇女多囊卵巢综合征易感性 被引量:1

Relationship between susceptibility of polycystic ovary syndrome and gene polymorphism of microsomal epoxide hydrolase in chinese women
原文传递
导出
摘要 目的:探讨微粒体环氧化物水解酶(EPHX)基因多态性与中国妇女多囊卵巢综合征(PCOS)发病易感性的关系。方法:用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析的方法检测115例PCOS病人和89例健康对照者EPHX基因外显子3(Tyr113→His)、外显子4(His139→yArg)基因型分布。结果:PCOS组和对照组基因型分布未见明显异常。两组外显子3和外显子4的基因型分布无统计学差异,P=0.185(exon3)和P=0.205(exon4);单点等位基因的分布也未见显著差别P=0.135(exon3)和P=0.135(exon4)。但对比预测的高、中、低和极低酶活性时发现高酶活性的基因突变相对于其他酶活性在PCOS疾病的发生上可以视为一种保护因素(OR=0.605,CI=0.158~2.324)。结论:由于基因变异导致的EPHX高活性基因型可能在多囊卵巢综合征的发病中起保护作用。 Objective: To explore the relationship between susceptibility of polycystic ovary syndrome (PCOS) and gene polymor- phism of microsomal epoxide hydrolase (EPHX) in chinese women. Methods: Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were performed to detect genotype EPHX polymorphism in exon3 (Tyr113→His) and exon4 (His139→Arg) from 115 PCOS women (case group) and 89 healthy women (control group) . Results: There was no significant difference in the distribution of genotypes in EPHX between case group and control group . Genotype distributions of exon 3 and exon 4 had no significant difference between two groups [ P = 0. 185 (exon3)][ P = 0. 205 (exon4) ] . There was no significant difference in the distribution of single point allele between two groups [ P = 0. 135 (exon3) 3 ][ P = 0. 135 (exon4) ] . There was positive correlation between genie mutation of high - activity EPHX and PCOS ( OR =0. 605, CI = 0. 158 - 2. 324 ) . Conclusion: Genetype of high - activity EPHX induced by genie mutation may play a role in the protection of PCOS.
出处 《中国妇幼保健》 CAS 北大核心 2009年第5期652-655,共4页 Maternal and Child Health Care of China
关键词 多囊卵巢综合征 微粒体环氧化物水解酶 基因 多态性 Polycystic ovary syndrome Microsomal epoxide hydrolase Gene Polymorphism
  • 相关文献

参考文献11

  • 1Hartsfield JK Jr, Sutcliffe M J, Everett ET et al. Assigamentl of microsareal epoxide hydrolase ( EPHX1 ) to haman chronosome lq42. 1 by in situ hybridization [J]. Cytogenet Cell Genet, 1998, 83:44
  • 2Lancaster JM, Brownlee HA, Bell DA et al. Microsomal epoxide hydrolase polymorphisB as a risk factor for ovarian cancer [ J]. Mol Carcinog, 1996, 17:160
  • 3Hassett C, Aicher L, Sidhu JS et al. Human nicrosamal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants [J]. Ham Mol Genet, 1994, 3:421
  • 4Rotterdam ESHRE/ASRM -Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long - teru health risks related to polycystic ovary syndrome [ J ]. Fertil Steril, 2004, 81 (1): 19
  • 5Pinarbasi E, Percin FE, Yilmaz M et al. Association of nicrosomal epoxide hydrolase gene polymorphism and pre - eclampsia in Turkish wonen [J]. J Obstet Gynaecol Res, 2007, 33 : 32
  • 6Korhonen S, Romppanen EL, Hihunen Id et al. Two Exonic single nucleotide polymorphisns in the micmsomal epoxide hydrolase gene are associated with polycystic ovary syndrome [ J ]. Fertil Steril, 2003, 79: 1353
  • 7Xing XY, Yang WY, Yang ZJ. The diagnostic significance of homeostasis model assessment of insulin resistance in metabolic syndrome auongsubjects with different glucose tolerance [ J] . Chinese Journal of Diabetes 2004 12:182
  • 8Vogel- Bindel U, Bentley P, Oesch F. Endogenous role of microsonal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of nicrosomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene -3 -one as substrate [J]. Eur J Biochem, 1982, 126:425
  • 9Hattori N, Fujiwara H, Maeda M et al. Epoxide hydrolase affects estrogen production in the human ovary [J]. Endocrinology, 2000, 141: 3353
  • 10Toivonen S, Romppanen EL, Hiltunen M et al. Low -activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption [J]. J Soc Gynecol Investig, 2004, 11 : 540

同被引文献10

  • 1Wang X, Wang M, Niu T, et al. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion [ J ]. Epidemiology, 1998,9(5) :540 -4.
  • 2Zusterzeel P L,Peters W H,Visser W,et al. A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia[ J]. J Med Genet,2001,38(4) :234-7.
  • 3Lancaster J M, Brownlee H A, Bell D A, et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer[ J]. Mol Carcinog, 1996,17 ( 3 ) : 160 - 2.
  • 4Korhonen S, Romppanen E L, Hiltunen M, et al. Two Exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome[ J]. Fertil Steri1,2003,79 ( 6 ) : 1353 - 7.
  • 5Seideggtrd J , DePierre J W. Microsomal epoxide hydrolase:Properties, regulation and function [ J ]. Biochim Biophys Acta, 1983,695 (3 -4) :251 -70.
  • 6Vogel-Bindel U, Bentley P, Oesch F. Endogenous role of microsom- al epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution,immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate[ J]. Eur J Biochem,1982,126(2) :425 -31.
  • 7Hattori N, Fujiwara H, Maeda M, et al. Epoxide hydrolase affects estrogen production in the human ovary [ J]. Endocrinology ,2000, 141 (9) :3353 -65.
  • 8Hartsfield J K,Sutcliffe M J,Everett E T,et al. Assigamentl of mierosomal epoxide hydrolase( EPHX1 )to human chromosome 1q42. 1 by in situ hybridization [ J ]. Cytogenet Cell Genet, 1998,83 (1- 2) :44 -5.
  • 9Hassett C, Aicher L, Sidhu J S, et al. Human microsomal Epoxide hydrolase:genetic polymorphism and functional expression in vitro of aminoacid variants[ J]. Hum Mol Genet, 1994,3 (3 ) :421 - 8.
  • 10李慧蓉,魏兆莲,曹云霞,丛林,周平.体重指数对多囊卵巢综合征患者IVF结局的影响[J].安徽医科大学学报,2010,45(1):109-112. 被引量:19

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部